Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Janoir

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|February 22, 2001
New mutation in parE in a pneumococcal in vitro mutant resistant to fluoroquinolonesC Janoir, E Varon, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|January 30, 1999
ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniaeE Varon, C Janoir, M D Kitzis, et al.
International Journal of Antimicrobial Agents|March 24, 2009
New trends in Clostridium difficile virulence and pathogenesisC Denève, C Janoir, I Poilane, et al.
Pathologie-Biologie|October 7, 2004
[Characterization of an extracellular protease from Clostridium difficile]C Janoir, J Grénery, M-P Savariau-Lacomme, et al.
The Journal of Infectious Diseases|July 9, 1999
In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitisC Janoir, I Podglajen, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrAC Janoir, V Zeller, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniaeV Zeller, C Janoir, M D Kitzis, et al.
New Microbes and New Infections|September 14, 2019
Virulence of new variant strains of <i>Clostridium difficile</i> producing only toxin A or binary toxin in the hamster modelJ-C Marvaud, S Quevedo-Torres, C Eckert, et al.
Anaerobe|October 28, 2015
Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal modelsJ-F Bruxelle, A Mizrahi, S Hoys, et al.
Anaerobe|June 4, 2018
Clostridium difficile forms variable biofilms on abiotic surfaceV Pantaléon, M Monot, C Eckert, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|February 22, 2001
New mutation in parE in a pneumococcal in vitro mutant resistant to fluoroquinolonesC Janoir, E Varon, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|January 30, 1999
ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniaeE Varon, C Janoir, M D Kitzis, et al.
International Journal of Antimicrobial Agents|March 24, 2009
New trends in Clostridium difficile virulence and pathogenesisC Denève, C Janoir, I Poilane, et al.
Pathologie-Biologie|October 7, 2004
[Characterization of an extracellular protease from Clostridium difficile]C Janoir, J Grénery, M-P Savariau-Lacomme, et al.
The Journal of Infectious Diseases|July 9, 1999
In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitisC Janoir, I Podglajen, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1996
High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrAC Janoir, V Zeller, M D Kitzis, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniaeV Zeller, C Janoir, M D Kitzis, et al.
New Microbes and New Infections|September 14, 2019
Virulence of new variant strains of <i>Clostridium difficile</i> producing only toxin A or binary toxin in the hamster modelJ-C Marvaud, S Quevedo-Torres, C Eckert, et al.
Anaerobe|October 28, 2015
Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal modelsJ-F Bruxelle, A Mizrahi, S Hoys, et al.
Anaerobe|June 4, 2018
Clostridium difficile forms variable biofilms on abiotic surfaceV Pantaléon, M Monot, C Eckert, et al.
Pageof 2